DMK Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012	2011 - 1995
Net Income	-26.48	-45.83	-49.39	-27.51	-39.01	-25.54	-20.81	-13.57	-8.16	-7.19	Upgrade
Depreciation & Amortization	1.48	1.44	2.33	2.96	3.1	3.06	2.53	0.99	0.3	0	Upgrade
Share-Based Compensation	-0.34	1.98	4.1	5.87	6.54	6.06	4.7	2.49	0.64	0.2	Upgrade
Other Operating Activities	-0.57	4.62	22.06	-1.2	-3.28	1.28	-8.96	-0.24	0.44	4.43	Upgrade
Operating Cash Flow	-25.9	-37.79	-20.9	-19.89	-32.66	-15.13	-21.16	-10.34	-6.78	-2.56	Upgrade
Capital Expenditures	-0.68	-1.22	-0.45	-2.87	-3.54	-2.06	-0.12	0	-0.1	0	Upgrade
Acquisitions	4.09	1.41	0	0	0	0	0.38	0	0	0	Upgrade
Other Investing Activities	0.07	0.1	-0.5	-	-	-0.03	-	-	-9.9	-	Upgrade
Investing Cash Flow	3.48	0.28	-0.95	-2.87	-3.54	-2.09	0.26	0	-10	0	Upgrade
Share Issuance / Repurchase	0	57.6	18.23	13.8	37.62	16.02	10.39	10.64	25.45	0	Upgrade
Debt Issued / Paid	0	1.77	3.19	-0.5	-0.49	-2.33	1.68	0	-1.35	2.55	Upgrade
Other Financing Activities	0.29	-5.43	-1.53	-1.01	-	16.77	9.85	-	-1.92	-	Upgrade
Financing Cash Flow	0.29	53.94	19.89	12.29	37.13	30.46	21.91	10.64	22.18	2.55	Upgrade
Net Cash Flow	-22.13	16.43	-1.96	-10.46	0.94	13.24	1.02	0.31	5.4	-0.01	Upgrade
Free Cash Flow	-26.58	-39.01	-21.35	-22.75	-36.19	-17.19	-21.28	-10.34	-6.88	-2.56	Upgrade
Free Cash Flow Margin	-558.88%	-1766.16%	-769.00%	-102.89%	-239.90%	-131.53%	-328.72%	-	-	-	Upgrade
Free Cash Flow Per Share	-12.42	-18.94	-19.27	-29.90	-64.82	-42.46	-85.12	-54.50	-65.53	-30.57	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).